Vistin Pharma ASA (FRA:VP4) Cyclically Adjusted FCF per Share: €-0.05 (As of Mar. 2026)


FRA:VP4 Vistin Pharma ASA FRA:VP4
80 GF Score
Price €1.79
GF Value €2.27
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Vistin Pharma ASA Cyclically Adjusted FCF per Share?

Vistin Pharma ASA FRA:VP4 -1.10% 80 Cyclically Adjusted FCF per Share is €-0.05 as of Mar. 2026. GuruFocus rates FRA:VP4 with a GF Score™ of 80/100 and a GF Value™ of €2.27 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Vistin Pharma ASA's adjusted free cash flow per share for the three months ended in Mar. 2026 was €-0.019. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-0.05 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-07), Vistin Pharma ASA's current stock price is €1.79. Vistin Pharma ASA's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €-0.05. Vistin Pharma ASA's Cyclically Adjusted Price-to-FCF of today is .


Vistin Pharma ASA  (FRA:VP4) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Vistin Pharma ASA Cyclically Adjusted FCF per Share Related Terms


Vistin Pharma ASA Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Vistin Pharma ASA's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vistin Pharma ASA Cyclically Adjusted FCF per Share Chart

Vistin Pharma ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.07 -0.04

Vistin Pharma ASA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.07 -0.07 -0.05 -0.04 -0.05

FRA:VP4 vs ZTS, UTHR, VTRS: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vistin Pharma ASA's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vistin Pharma ASA Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vistin Pharma ASA's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Vistin Pharma ASA's Cyclically Adjusted Price-to-FCF falls into.


FRA:VP4
80GF Score
Vistin Pharma ASA FRA:VP4
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vistin Pharma ASA Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vistin Pharma ASA's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.019/141.0300*141.0300
=-0.019

Current CPI (Mar. 2026) = 141.0300.

Vistin Pharma ASA Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.010 103.800 -0.014
201609 0.106 104.200 0.143
201612 0.106 104.400 0.143
201703 -0.151 105.000 -0.203
201706 0.067 105.800 0.089
201709 -0.167 105.900 -0.222
201712 0.077 106.100 0.102
201803 -0.115 107.300 -0.151
201806 -0.071 108.500 -0.092
201809 -0.007 109.500 -0.009
201812 -0.023 109.800 -0.030
201903 -0.044 110.400 -0.056
201906 -0.020 110.600 -0.026
201909 0.034 111.100 0.043
201912 0.047 111.300 0.060
202003 -0.005 111.200 -0.006
202006 -0.342 112.100 -0.430
202009 -0.023 112.900 -0.029
202012 -0.047 112.900 -0.059
202103 0.023 114.600 0.028
202106 -0.002 115.300 -0.002
202109 -0.014 117.500 -0.017
202112 -0.048 118.900 -0.057
202203 -0.052 119.800 -0.061
202206 -0.102 122.600 -0.117
202209 0.002 125.600 0.002
202212 -0.015 125.900 -0.017
202303 0.047 127.600 0.052
202306 0.045 130.400 0.049
202309 -0.001 129.800 -0.001
202312 0.052 131.900 0.056
202403 -0.024 132.600 -0.026
202406 0.014 133.800 0.015
202409 0.066 133.700 0.070
202412 0.073 134.800 0.076
202503 0.001 136.100 0.001
202506 0.006 137.800 0.006
202509 0.046 138.500 0.047
202512 0.065 139.100 0.066
202603 -0.019 141.030 -0.019

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-0.05 mean?
Vistin Pharma ASA (FRA:VP4) has a Cyclically Adjusted FCF per Share of €-0.05 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Vistin Pharma ASA and its competitors.
Is Vistin Pharma ASA's Cyclically Adjusted FCF per Share too high?
Vistin Pharma ASA's current Cyclically Adjusted FCF per Share is €-0.05. Overall, Vistin Pharma ASA has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vistin Pharma ASA's Cyclically Adjusted FCF per Share compare to ZTS and UTHR?
Vistin Pharma ASA's Cyclically Adjusted FCF per Share of €-0.05 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Vistin Pharma ASA and its competitors. Vistin Pharma ASA's current Cyclically Adjusted FCF per Share is €-0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vistin Pharma ASA stock overvalued right now?
Based on GuruFocus' analysis, Vistin Pharma ASA (FRA:VP4) is currently considered Modestly Undervalued. The stock's GF Value™ is €2.27, compared to a current price of €1.79 — trading 21.1% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €-0.05. Vistin Pharma ASA's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Vistin Pharma ASA (FRA:VP4), the current Cyclically Adjusted FCF per Share is €-0.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vistin Pharma ASA (FRA:VP4) Overvalued in 2026?

Based on GuruFocus' analysis, Vistin Pharma ASA stock appears to be undervalued. The current stock price of €1.79 is trading 21.1% below its estimated GF Value™ of €2.27. GuruFocus considers Vistin Pharma ASA to be Modestly Undervalued.

Key valuation signals for FRA:VP4:

  • Cyclically Adjusted FCF per Share: €-0.05
  • GF Value™: €2.27 vs. price of €1.79 (21.1% below fair value)
  • GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the FRA:VP4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vistin Pharma ASA Business Description

Address Ostensjoveien 27, P.O. Box 6735 Etterstad, Oslo, NOR, 0661
Vistin Pharma ASA is a pharmaceutical company engaged in the production and supply of active pharmaceutical ingredients (APIs). The company operates in one business segment, Pharmaceuticals, and is a supplier of Metformin, which is used as a standard treatment for Type 2 diabetes. The company generates revenue across multiple geographic regions, including Africa, Europe, Asia, and North and South America.
80GF Score

Get the complete analysis for FRA:VP4

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.79
Price
€2.27
GF Value